Mariner Wealth Advisors (Cincinnati)’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-58,732
Closed -$12M 295
2017
Q3
$12M Buy
58,732
+4,046
+7% +$941K 0.78% 49
2017
Q2
$13.3M Buy
54,686
+46,102
+537% +$10.8M 0.92% 45
2017
Q1
$2.05M Buy
8,584
+2,954
+52% +$688K 0.15% 92
2016
Q4
$1.18M Sell
5,630
-2,844
-34% -$589K 0.09% 112
2016
Q3
$1.95M Sell
8,474
-32,166
-79% -$7.86M 0.17% 96
2016
Q2
$9.39M Buy
40,640
+3,004
+8% +$693K 0.84% 45
2016
Q1
$10.1M Buy
37,636
+1,491
+4% +$427K 0.99% 39
2015
Q4
$11.3M Buy
+36,145
New +$10.8M 1.1% 39

Other funds holding AGN

Mariner Wealth Advisors (Cincinnati)'s AGN Position: Q4 2017 in Review

Mariner Wealth Advisors (Cincinnati) sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 58,732 shares — an estimated $12M sold.

Mariner Wealth Advisors (Cincinnati) first reported a position in AGN in Q4 2015 and held it in 8 quarters. The position peaked at $13.3M in Q2 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Mariner Wealth Advisors (Cincinnati) reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Mariner Wealth Advisors (Cincinnati) sold 58,732 Allergan plc shares in Q4 2017, an estimated $12M.
  • Mariner Wealth Advisors (Cincinnati) first reported a position in Allergan plc in Q4 2015 and held it in 8 quarters.
  • Mariner Wealth Advisors (Cincinnati)'s Allergan plc position peaked at $13.3M in Q2 2017.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Mariner Wealth Advisors (Cincinnati)'s 13F filing for Q4 2017, filed 12 Feb 2018.